media centre
Join us @ Keystone! March 24-28 Innate and Non-Classical Immune Cells in Cancer Immunotherapy
20 February
media centre
All media
All media
Twitter
Feed
news
news
publications
publications
schedule
schedule
CAR T cells work better when they are NK...
NK cell activity (frequency and function...
Sensitization to immune checkpoint block...
Congrats @MonashBDI Another suppressive...
Need more R&D in this country. Not l...
If only all tumor CRISPR screens were th...
Hey @Dr_Nick_Bikes, nice new @MonashBDI ...
A great read about the long road to cell...
We we're tremendously impressed by the q...
Our CSO @Dr_Nick_Bikes at #ShineDome19 w...
Next sabbatical in here at oNKo please!
Our CSO & @MonashUni Cancer Immunoth...
MIN2019 Early Bird Rego ends TODAY! We'r...
@DrMistyJenkins @unimelb @WEHI_research ...
Congratulations to our CSO @Dr_Nick_Bike...
Register here for Melbourne's largest an...
Quantifying NK cell growth and survival ...
Great work team! https://t.co/K5YM8Ps44o
Throwback Tuesday to the academic work r...
Harnessing the 'Natural Killer' within u...
A simply amazing response to the recent ...
Only 10 days till the first @KeystoneSym...
Congratulations to our CSO for winning the 2019 Jacques Miller Medal
Well deserved recognition. Congrats to o...
Join us @ Keystone! March 24-28 Innate and Non-Classical Immune Cells in Cancer Immunotherapy
Amazing response to the @KeystoneSymp th...
@LorneCancer conference starts today. Se...
He eats, sleeps, breathes and drives NKC...
31st Annual Lorne Cancer Conference
The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
We are LIVE! https://t.co/fu8vunDAEv Ch...
Did you know that NK cells can recognize...
RT @JoeCursons: Off to a flying start fo...
RT @JohnCendpts: Bristol-Myers inks a $7...
Welcome to our new website!